company background image
SANG

Sanginita Chemicals NSEI:SANGINITA Stock Report

Last Price

₹20.00

Market Cap

₹345.4m

7D

1.8%

1Y

-11.9%

Updated

24 Jun, 2022

Data

Company Financials
SANGINITA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance1/6
Financial Health3/6
Dividends0/6

SANGINITA Stock Overview

Sanginita Chemicals Limited manufactures and exports cuprous chloride, cupric chloride, and copper sulphate in India.

Sanginita Chemicals Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Sanginita Chemicals
Historical stock prices
Current Share Price₹20.00
52 Week High₹47.20
52 Week Low₹17.75
Beta0.27
1 Month Change-2.20%
3 Month Change-8.88%
1 Year Change-11.89%
3 Year Change-68.99%
5 Year Changen/a
Change since IPO-61.91%

Recent News & Updates

Feb 15
We Think Sanginita Chemicals (NSE:SANGINITA) Is Taking Some Risk With Its Debt

We Think Sanginita Chemicals (NSE:SANGINITA) Is Taking Some Risk With Its Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

SANGINITAIN ChemicalsIN Market
7D1.8%-0.4%0.1%
1Y-11.9%-2.6%-1.7%

Return vs Industry: SANGINITA underperformed the Indian Chemicals industry which returned -2.6% over the past year.

Return vs Market: SANGINITA underperformed the Indian Market which returned -1.7% over the past year.

Price Volatility

Is SANGINITA's price volatile compared to industry and market?
SANGINITA volatility
SANGINITA Average Weekly Movement8.6%
Chemicals Industry Average Movement6.8%
Market Average Movement6.9%
10% most volatile stocks in IN Market9.8%
10% least volatile stocks in IN Market4.5%

Stable Share Price: SANGINITA is more volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: SANGINITA's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
200529Dineshsinh Chavadahttps://www.sanginitachemicals.co.in

Sanginita Chemicals Limited manufactures and exports cuprous chloride, cupric chloride, and copper sulphate in India. The company also offers copper phthalocyanine blue crude. Its products are used in dyes and pigment industries, paint industries, pharmaceuticals industries, electroplating industries, metal extraction industries and ink, carbon paper, PVC pipe coating industries, etc. Sanginita Chemicals Limited was incorporated in 2005 and is headquartered in Gandhinagar, India.

Sanginita Chemicals Fundamentals Summary

How do Sanginita Chemicals's earnings and revenue compare to its market cap?
SANGINITA fundamental statistics
Market Cap₹345.35m
Earnings (TTM)₹3.48m
Revenue (TTM)₹1.98b

99.2x

P/E Ratio

0.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SANGINITA income statement (TTM)
Revenue₹1.98b
Cost of Revenue₹1.91b
Gross Profit₹66.39m
Other Expenses₹62.91m
Earnings₹3.48m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.20
Gross Margin3.35%
Net Profit Margin0.18%
Debt/Equity Ratio86.9%

How did SANGINITA perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is SANGINITA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SANGINITA?

Other financial metrics that can be useful for relative valuation.

SANGINITA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.3x
Enterprise Value/EBITDA22.2x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does SANGINITA's PE Ratio compare to its peers?

SANGINITA PE Ratio vs Peers
The above table shows the PE ratio for SANGINITA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average11x

Price-To-Earnings vs Peers: SANGINITA is expensive based on its Price-To-Earnings Ratio (99.2x) compared to the peer average (11x).


Price to Earnings Ratio vs Industry

How does SANGINITA's PE Ratio compare vs other companies in the Indian Chemicals Industry?

Price-To-Earnings vs Industry: SANGINITA is expensive based on its Price-To-Earnings Ratio (99.2x) compared to the Indian Chemicals industry average (16.8x)


Price to Earnings Ratio vs Fair Ratio

What is SANGINITA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SANGINITA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio99.2x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SANGINITA's Price-To-Earnings Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of SANGINITA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SANGINITA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SANGINITA's fair value for valuation analysis.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SANGINITA's PEG Ratio to determine if it is good value.


Discover undervalued companies

Future Growth

How is Sanginita Chemicals forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.6%

Forecasted Materials industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanginita Chemicals has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Take a look at our analysis of SANGINITA’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Sanginita Chemicals competitive advantages and company strategy can generally be found in its financial reports archived here.

Past Performance

How has Sanginita Chemicals performed over the past 5 years?

Past Performance Score

1/6

Past Performance Score 1/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-23.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: SANGINITA has high quality earnings.

Growing Profit Margin: SANGINITA's current net profit margins (0.2%) are lower than last year (0.5%).


Past Earnings Growth Analysis

Earnings Trend: SANGINITA's earnings have declined by 23.9% per year over the past 5 years.

Accelerating Growth: SANGINITA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SANGINITA had negative earnings growth (-54.4%) over the past year, making it difficult to compare to the Chemicals industry average (29.6%).


Return on Equity

High ROE: SANGINITA's Return on Equity (0.9%) is considered low.


Discover strong past performing companies

Financial Health

How is Sanginita Chemicals's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: SANGINITA's short term assets (₹748.6M) exceed its short term liabilities (₹358.9M).

Long Term Liabilities: SANGINITA's short term assets (₹748.6M) exceed its long term liabilities (₹35.9M).


Debt to Equity History and Analysis

Debt Level: SANGINITA's net debt to equity ratio (86.9%) is considered high.

Reducing Debt: SANGINITA's debt to equity ratio has reduced from 92.2% to 86.9% over the past 5 years.

Debt Coverage: SANGINITA's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: SANGINITA's interest payments on its debt are not well covered by EBIT (1.2x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Sanginita Chemicals's current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate SANGINITA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SANGINITA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SANGINITA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SANGINITA's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as SANGINITA has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

5.6yrs

Average management tenure


CEO

Dineshsinh Chavada (62 yo)

6.42yrs

Tenure

₹600,000

Compensation

Mr. Dineshsinh Bhimsinh Chavada has been Managing Director of Sanginita Chemicals Limited since November 23, 2016 and has been its Executive Director since January 1, 2007. Mr. Chavada has many years of ex...


CEO Compensation Analysis

Compensation vs Market: Dineshsinh's total compensation ($USD7.68K) is below average for companies of similar size in the Indian market ($USD38.35K).

Compensation vs Earnings: Dineshsinh's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SANGINITA's management team is seasoned and experienced (5.6 years average tenure).


Board Members

Experienced Board: SANGINITA's board of directors are seasoned and experienced ( 10.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SANGINITA insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sanginita Chemicals Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Sanginita Chemicals Limited
  • Ticker: SANGINITA
  • Exchange: NSEI
  • Founded: 2005
  • Industry: Commodity Chemicals
  • Sector: Materials
  • Implied Market Cap: ₹345.354m
  • Shares outstanding: 17.27m
  • Website: https://www.sanginitachemicals.co.in

Number of Employees


Location

  • Sanginita Chemicals Limited
  • 301, Shalin Complex
  • 3rd Floor
  • Gandhinagar
  • Gujarat
  • 382011
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/24 00:00
End of Day Share Price2022/06/24 00:00
Earnings2022/03/31
Annual Earnings2022/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.